Signaling pathways
-
BA5820 DOTA-JR11Summary: DOTA-JR11 is an antagonist of the growth inhibitory receptor. - BA5821 NF-56-EJ40Summary: NF-56-EJ40 is a potent, high affinity and highly selective human antagonist.
- BA5822 SUCNR1-IN-1Summary: SUCNR1-IN-1 is an inhibitor (88 nM for hSUCNR1).
- BA5823 RO5256390Summary: RO5256390 is an agonist of trace amine-associated receptor 1, a highly conserved G protein-coupled receptor (GPCR) bound by endogenous trace amines.
-
BA5824 RO5166017Summary: RO5166017 is an orally active, cross-species agonist. - BA5825 RO5263397Summary: RO5263397 is a potent, selective and oral agonist.
- BA5826 ZH8651Summary: ZH8651 is an agonist that activates both Gs and Gq signaling pathways.
- BA5827 ML-109Summary: ML-109 is a potent, full agonist of the thyrotropin receptor.
- BA5828 Org41841Summary: ORG41841 is a partial agonist of luteinizing hormone/chorionic gonadotropin receptor and thyrotropin receptor.
- BA5829 NCGC00229600Summary: NCGC00229600 is a variant inverse agonist.